Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition, Bristol-Myers Squibb will ...
Jefferies analyst Akash Tewari maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report) today and set a price target of ...
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...
The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...
Green, a former pharmacist and pharma ad copywriter whose resume includes such agencies as Grey Healthcare and KPR (since ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN – Research Report), Rhythm ...
Glen Mills native Jim Cassady has given up his job in digital marketing at Bristol Myers Squibb so he can saturate Delaware ...
Jason Kim has been appointed chief financial officer at Enveda Biosciences, a biotechnology company using artificial ...
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
Hosted on MSN4d
At J.P. Morgan Healthcare Conference, Korean pharmaceuticals set to share strategies, seal dealsThe 43rd J.P. Morgan Healthcare Conference in San Francisco will see active participation by Korean pharmaceutical giants and ...
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback